neutralising antibody
Modulation of the virus receptor interaction by mutations in the V5 loop of feline immunodeficiency virus (FIV) following in vivoescape from neutralising antibody
13
Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves
22
The association between age and the development of respiratory syncytial virus neutralising antibody responses following natural infection in infants
5
Effect of sclerostin neutralising antibody on periarticular and systemic bone in a murine model of rheumatoid arthritis: a microCT study
12
Seroprevalence of Rift Valley fever and lumpy skin disease in African buffalo (Syncerus caffer) in the Kruger National Park and Hluhluwe-iMfolozi Park, South Africa
7
Studies on defective interfering Semliki Forest virus
295
Secreted HMGB1 from Wnt activated intestinal cells is required to maintain a crypt progenitor phenotype
9
Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules
13
The effect of the TLR9 ligand CpG-oligodeoxynucleotide on the protective immune response to alcelaphine herpesvirus-1-mediated malignant catarrhal fever in cattle
11
Efficient generation of vesicular stomatitis virus (VSV)-pseudotypes bearing morbilliviral glycoproteins and their use in quantifying virus neutralising antibodies
9
Yeast expressed recombinant Hemagglutinin protein of Novel H1N1 elicits neutralising antibodies in rabbits and mice
13
Duration of protective immunity and antibody responses in cattle immunised against alcelaphine herpesvirus-1-induced malignant catarrhal fever
11
Induction of neutralising antibodies by virus like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses
7
Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010
12
Analysis of the function of IL-10 in chickens using specific neutralising antibodies and a sensitive capture ELISA
7
Towards a Belgian position on Brexit: Actively reconciling national and European interests Egmont Paper 99, November 2017
26
The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
8
The Multilateral Tax Instrument: How to Avoid a Stalemate on Distributional Issues?
24
ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice
9
Comparison of fluorescent antibody, neutralizing antibody, and complement enhanced neutralizing antibody assays for detection of serum antibody to respiratory syncytial virus
6